Cardiovascular effects of methylphenidate, risperidone, and their combination in children and adolescents with attention-deficit/hyperactivity disorder: a prospective 3-month observational study

CONCLUSION: Treatment with methylphenidate, risperidone, and combination therapy was associated with modest changes in heart rate, blood pressure, and QTc interval over three months. These findings highlight the importance of baseline and follow-up cardiovascular monitoring in children and adolescents receiving ADHD medications.

via https://pubmed.ncbi.nlm.nih.gov/42983349/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1L37KAMf2b_g4WEK3LmdFuKZu9pO3cN7u4ZmO9PPCPeBLMIw1q&fc=None&ff=20261116041633&v=2.20.1


Post a Comment

Your email is never published nor shared. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>